INBX
Inhibrx Biosciences, Inc.
99.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +57.7% | +69.4% | +72.0% | -12.4% | +17.3% | +2.5% | -2.8% | +91.9% | +8.7% | |
| – | +114.5% | +109.8% | +60.0% | +26.4% | +199.6% | +35.9% | +21.5% | +135.5% | -81.0% | |
| – | – | +325.1% | -17.9% | +264.2% | -238.0% | – | +385.4% | +239.1% | -114.6% | |
| – | +523.3% | +6.6% | +26.7% | -24.6% | -36.7% | -20.6% | +569.5% | -43.5% | -98.8% | |
| – | +523.3% | +6.6% | +26.7% | -24.6% | -40.7% | -15.2% | +569.5% | -43.5% | -98.9% | |
| – | – | -39.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -52.9% | -2.8% | +229.4% | +284.2% | -49.7% | +208.6% | -21.9% | -64.5% | +41.5% | |
| – | -162.8% | – | – | +1,141.1% | -97.7% | +5,306.3% | -97.2% | -3,187.7% | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.